Women's and Children's Service, Sunshine Coast University Hospital (SCUH), Sunshine Coast Hospital and Health Service District (SCHHS), Sunshine Coast, Australia.
Queensland Cerebral Palsy and Rehabilitation Research Centre, Faculty of Medicine, The University of Queensland, Child Health Research Centre, Brisbane, Australia.
Dev Med Child Neurol. 2023 Mar;65(3):346-357. doi: 10.1111/dmcn.15381. Epub 2022 Sep 17.
This study aimed to identify early clinical biomarkers from birth to 16 weeks corrected age to predict typical outcome and developmental delay in infants born very preterm or with very low birthweight.
A prospective cohort of infants on the Sunshine Coast, Australia, was assessed using the Premie-Neuro Examination, the General Movement Assessment (GMA), the Alberta Infant Motor Scale, and the Infant Sensory Profile 2. At 24 months corrected age, delay was identified using the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) and Neurosensory Motor Developmental Assessment (NSMDA).
One hundred and four infants were recruited; 79 completed outcome assessments (43 females, 36 males; mean gestational age 30 weeks [SD 1 week 6 days], mean birthweight 1346 g [SD 323]). The incidence of developmental delay (motor or cognitive) was 6.3%. Suboptimal quality of fidgety general movements (temporal organization) at 16 weeks corrected age demonstrated the best predictive accuracy (Bayley-III motor: sensitivity 100% [95% confidence interval {CI} 3-100], specificity 75% [95% CI 63-84], area under the curve [AUC] 0.87); Bayley-III cognitive: sensitivity 100% [95% CI 3-100], specificity 75% [95% CI 64-84], AUC 0.88); NSMDA motor: sensitivity 100% [95% CI 40-100], specificity 81% [95% CI 70-90], AUC 0.91 [95% CI 0.86-0.95]). GMA trajectories that combined abnormal writhing general movements at 4 to 5 weeks corrected age with suboptimal quality of fidgety movement at 16 weeks corrected age were strongly predictive of developmental delay, superior to all other clinical tools, and perinatal and demographic variables investigated (p = 0.01, Akaike information criterion method 18.79 [score corrected for small sample size], accounting for 93% of the cumulative weight).
Only the GMA had sufficient predictive validity to act as a biomarker for both conditions: typical outcome and developmental delay (motor or cognitive). GMA trajectories that assessed both writhing general movements at 4 to 5 weeks corrected age and quality of fidgety movement at 16 weeks corrected age predicted adverse neurodevelopmental outcome, accurately differentiating between infants with typical outcomes and those at increased risk for motor or cognitive delay.
本研究旨在确定从出生到 16 周校正年龄的早期临床生物标志物,以预测极早产儿或极低出生体重儿的典型结局和发育迟缓。
在澳大利亚阳光海岸对前瞻性队列的婴儿进行评估,使用早产儿神经检查、一般性运动评估(GMA)、阿尔伯塔婴儿运动量表和婴儿感觉概况 2 进行评估。在 24 周校正年龄时,使用贝利婴幼儿发育量表,第三版(Bayley-III)和神经感觉运动发育评估(NSMDA)确定发育迟缓。
共招募了 104 名婴儿;79 名完成了结局评估(43 名女性,36 名男性;平均胎龄 30 周[1 周 6 天标准差],平均出生体重 1346g[323g 标准差])。发育迟缓(运动或认知)的发生率为 6.3%。16 周校正年龄时烦躁不安的一般性运动(时间组织)质量不佳显示出最佳的预测准确性(Bayley-III 运动:敏感性 100%[95%置信区间{CI}3-100],特异性 75%[95%CI 63-84],曲线下面积[AUC]0.87);Bayley-III 认知:敏感性 100%[95%CI 3-100],特异性 75%[95%CI 64-84],AUC 0.88);NSMDA 运动:敏感性 100%[95%CI 40-100],特异性 81%[95%CI 70-90],AUC 0.91[95%CI 0.86-0.95])。4 至 5 周校正年龄时异常扭动的 GMA 轨迹与 16 周校正年龄时烦躁不安运动质量不佳相结合,强烈预测发育迟缓,优于所有其他临床工具和研究的围产期和人口统计学变量(p=0.01,Akaike 信息准则方法 18.79[得分校正小样本量],占累积权重的 93%)。
只有 GMA 具有足够的预测有效性,可以作为两种情况的生物标志物:典型结局和发育迟缓(运动或认知)。评估 4 至 5 周校正年龄时扭动的一般性运动和 16 周校正年龄时烦躁不安运动质量的 GMA 轨迹预测了不良的神经发育结局,准确地区分了具有典型结局的婴儿和有运动或认知迟缓风险增加的婴儿。